solv
crystal
molecular
structur
hepat
viral
hav
proteinas
cystein
peptidas
chymotrypsinlik
protein
fold
complex
three
tetrapeptidylbas
methyl
keton
inhibitor
resolut
beyond
highest
resolut
date
eg
sar
viral
main
proteinas
peptidas
residu
motif
residu
extens
two
ctermin
hav
critic
interact
enzym
tetrapeptid
portion
inhibitor
analog
residu
posit
natur
substrat
picornavir
proteinas
unexpectedli
form
two
coval
bond
inhibitor
yield
unusu
episulfid
cation
thiiranium
ring
stabil
nearbi
oxyanion
result
suggest
mechan
inactiv
peptidas
methyl
keton
inhibitor
distinct
occur
structur
relat
serin
proteinas
papainlik
cystein
peptidas
also
provid
insight
mechan
underli
inactiv
hav
inhibitor
proteolysi
natur
substrat
viral
cystein
peptidas
hepat
viru
belong
picornavirida
larg
famili
posit
singlestrand
rna
virus
also
includ
polioviru
pv
footandmouth
diseas
viru
fmdv
human
rhinovirus
hrv
base
extens
similar
genom
organ
like
basic
featur
viral
life
cycl
cell
also
similar
upon
entri
cytoplasm
suscept
cell
viral
rna
genom
translat
host
ribosom
produc
larg
polyprotein
subsequ
proteolyt
cleavag
polyprotein
viral
encod
peptidas
case
unknown
host
peptidas
lead
matur
viral
protein
perform
key
function
replic
viral
rna
genom
assembl
progeni
virion
virushost
antagon
latter
includ
inhibit
cellular
mrna
translat
transcript
inhibitioninduct
apoptosi
membran
vesicular
picornavirus
polyprotein
process
viru
peptidas
although
peptidas
enteroand
rhinovirus
small
leader
proteinas
aphthovirus
particip
minor
extent
peptidas
also
occur
calicivirus
coronavirus
play
major
role
polyprotein
process
virus
although
coronavir
polyprotein
consider
larger
enzym
cystein
peptidas
fold
also
similar
chymotrypsin
rather
papain
peptidas
addit
domain
mediat
homodimer
thought
critic
enzymat
activ
catalyt
mechan
thought
proceed
via
tetrahedr
intermedi
result
nucleophil
attack
carbonyl
carbon
scissil
bond
catalyt
cystein
residu
hav
howev
mani
mechanist
detail
remain
unknown
detail
understand
atom
resolut
enzym
cleav
cognat
substrat
would
greatli
facilit
ration
design
antivir
drug
knowledg
help
control
danger
pathogen
event
pandem
outbreak
recent
fmdv
epidem
england
caus
signific
loss
anim
accompani
financi
woe
use
substrat
analogu
inhibitor
probe
enzymat
mechan
long
tradit
research
proteinas
peptidyl
chloromethyl
keton
react
papain
serin
proteinas
dissimilar
way
yield
differ
type
coval
adduct
catalyt
residu
chymotrypsin
form
coval
linkag
carbonyl
carbon
chloromethyl
keton
inhibitor
result
tetrahedr
geometri
thought
mimic
transit
state
occur
hydrolysi
natur
substrat
addit
n
atom
attack
halogen
yield
second
coval
attach
inhibitor
alkyl
enzym
chloromethyl
function
replac
chloroethyl
group
inhibitor
alkyl
retent
configur
chiral
center
togeth
kinet
studi
indic
intern
nucleophil
displac
chlorid
newli
form
oxyanion
tetrahedr
intermedi
lead
ether
adduct
open
histidin
contrast
papain
inactiv
direct
coval
linkag
atom
halogen
class
inhibitor
imidazol
ring
papain
implic
proton
leav
group
due
shift
orient
posit
inplan
atom
posit
inplan
inhibitor
atom
equival
n
scissil
bond
howev
unclear
whether
revers
format
tetrahedr
intermedi
occur
prior
alkyl
sequenc
analys
indic
residu
hav
form
canon
catalyt
triad
howev
confirm
structur
hydrogen
bond
n
observ
recent
crystal
structur
hav
complex
bbl
nbenzyloxycarbonyl
cbz
inhibitor
fortuit
crystal
inhibitor
bbl
bind
coval
surfac
residu
near
rna
bind
motif
leav
proteolyt
activ
site
catalyt
residu
unobstruct
report
crystal
structur
hav
complex
three
tetrapeptidyl
inhibitor
nacetylleucylalanylalanyl
n
ndimethyl
glutaminefluoromethylketon
aclaaq
mm
fmk
inhibitor
ia
nacetylleucylphenylalanylphenylalanylglutamatefluoromethylketon
aclffefmk
inhibitor
ii
nacetylleucylalanylalanyl
n
ndimethyl
glutamin
methylketon
aclaaq
mm
pmk
inhibitor
ib
figur
complex
obtain
soak
method
use
pregrown
crystal
hav
peptidyl
portion
inhibitor
ia
ib
offer
fairli
good
resembl
favor
sequenc
posit
cleavag
site
hav
viral
polyprotein
inhibitor
ii
includ
studi
mimet
less
optim
substrat
laaq
sequenc
inhibitor
ia
ib
mainli
due
substitut
gln
glu
ala
phe
posit
peptidyl
portion
sequenc
align
analysi
natur
occur
cleavag
site
hav
proteinas
hepat
viral
polyprotein
indic
clear
prefer
small
residu
serin
threonin
posit
avail
structur
inform
strongli
support
conclus
furthermor
glutam
occasion
occur
residu
natur
cleavag
site
within
picornavir
polyprotein
although
much
lower
frequenc
glutamin
interest
understand
interact
hav
enzym
peptidyl
inhibitor
influenc
amino
acid
makeup
inhibitor
substrat
recognit
site
hav
identifi
crystallograph
coval
linkag
occur
inhibitor
interestingli
unusu
episulfid
cation
thiiranium
ring
observ
catalyt
cystein
residu
crystal
enzymeinhibitor
complex
format
nativ
variant
form
hav
protein
crystal
sever
differ
crystal
form
recent
report
crystal
variant
hav
space
group
structur
evid
three
catalyt
residu
proteolyt
activ
site
form
canon
triad
assembl
observ
chymotrypsinlik
serin
proteinas
picornavir
enzym
furthermor
earlier
crystal
structur
inactiv
form
hav
contain
either
substitut
catalyt
cystein
residu
oxid
form
therebi
complic
studi
enzymesubstrateinhibitor
interact
inde
soak
substratelik
inhibitor
pregrown
crystal
activ
site
variant
hav
met
littl
success
hav
crystal
form
incub
variant
bbl
use
subsequ
bind
three
tetrapeptidylbas
inhibitor
figur
analysi
soak
crystal
mass
spectrometri
reveal
differ
mass
ib
within
experiment
error
calcul
molecular
mass
acetyllaa
n
ndimethyl
qmethylen
data
shown
suggest
phthalhydrazid
group
lost
coval
attach
inhibitor
ib
hav
enzym
fashion
similar
loss
fluorid
two
inhibitor
previou
studi
vitro
inhibit
hav
inhibitor
ia
show
ic
valu
use
partial
viral
polyprotein
substrat
moreov
ad
havinfect
cell
concentr
inhibitor
ia
reduc
viral
yield
indic
much
lower
ic
valu
vivo
efficaci
inhibitor
cell
probabl
due
combin
effect
includ
irrevers
inhibit
fact
polyprotein
process
upstream
mani
key
replic
event
hav
infect
therefor
even
partial
block
proteinas
function
inhibitor
ia
would
profound
impact
progeni
virion
product
inhibit
hav
inhibitor
ib
studi
initi
use
short
time
cours
min
low
concentr
fluorogen
substrat
minim
latter
cleavag
selfquench
condit
potent
competit
inhibit
observ
ic
valu
current
studi
extens
time
cours
studi
demonstr
initi
competit
inhibit
figur
follow
slow
inactiv
hav
inhibitor
ib
irrevers
timedepend
fashion
figur
b
agreement
structur
data
present
hav
form
essenti
complex
inhibitor
ia
ib
ic
valu
inhibitor
ib
estim
close
previous
report
valu
figur
enzymat
activ
detect
hav
incub
inhibitor
ib
h
prior
activ
assay
indic
irrevers
natur
inactiv
figur
b
control
sampl
hav
incub
h
prior
assay
lose
activ
detect
structur
analysi
reveal
differ
overal
protein
fold
interact
among
three
new
complex
figur
three
new
structur
bbl
bound
n
atom
manner
structur
averag
rmsd
valu
three
new
structur
report
rang
c
posit
residu
tabl
suggest
littl
structur
rearrang
requir
bind
substrateanalogu
inhibitor
confirm
previou
claim
crystal
enzym
catalyt
form
major
part
motif
sit
atop
catalyt
residu
hav
residu
help
form
subsit
substrat
bind
vide
infra
complex
inhibitor
ia
ib
share
greater
structur
similar
inhibitor
ii
complex
tabl
support
hypothesi
inhibitor
ia
ib
react
similarli
activ
site
despit
differ
substitu
termin
two
inhibitor
addit
sinc
inhibitor
ia
ii
fluoromethyl
keton
differ
tetrapeptidyl
sequenc
must
key
caus
structur
diverg
suggest
hav
use
subtl
structur
adjust
measur
bind
fit
inhibitorsubstr
structur
differ
inhibitor
ia
ii
complex
consist
hav
prefer
small
residu
posit
cleavag
site
glutamin
posit
peptidyl
portion
three
keton
inhibitor
form
canon
interact
enzym
via
four
hydrogen
bond
mainchain
n
mainchain
n
one
side
mainchain
n
mainchain
n
figur
tabl
slightli
twist
shown
rel
angl
hydrogen
bond
allow
optim
interact
sidechain
inhibitor
correspond
substrat
bind
site
site
enzym
addit
mainchain
n
atom
residu
inhibitor
ia
ib
form
hydrogen
bond
mainchain
atom
interact
observ
inhibitor
ii
complex
structur
longer
correspond
distanc
like
result
nonoptim
bind
residu
inhibitor
ii
site
see
structur
observ
accord
well
previou
biochem
data
indic
residu
primarili
determin
specif
enzymesubstr
interact
site
hav
quit
well
defin
wherea
site
discern
sidechain
residu
inhibitor
simpli
protrud
solvent
site
form
sidechain
atom
mainchain
atom
neither
wide
deep
enough
accommod
larg
hydrophob
residu
phe
consequ
residu
inhibitor
ii
enter
pocket
angl
benzen
moieti
bend
toward
solvent
entranc
pocket
stack
imidazol
ring
tabl
site
shallow
depress
surfac
hav
cluster
sidechain
hydrophob
residu
name
form
hydrophob
interact
sidechain
atom
inhibitor
final
site
paramount
import
substrat
recognit
form
residu
one
wall
residu
sit
bottom
pocket
back
end
opposit
imidazol
sidechain
lock
particular
tautomer
conform
hydrogen
bond
n
atom
one
two
buri
water
molecul
also
hydrogen
bond
carboxyl
pois
interact
residu
incom
peptidyl
substrat
atom
glutamin
residu
would
form
optim
hydrogen
bond
n
atom
inde
atom
mm
either
inhibitor
ia
ib
distanc
n
atom
interest
note
neither
carboxyl
oxygen
atom
inhibitor
ii
form
direct
hydrogen
bond
instead
atom
hydrogen
bond
n
atom
via
bridg
water
molecul
distanc
former
latter
atom
respect
crystal
structur
complex
similar
water
molecul
form
hydrogen
bond
n
atom
compar
distanc
similarli
solvent
molecul
also
form
hydrogen
bond
equival
specificitydetermin
residu
fmdv
tgev
crystal
structur
serin
proteinas
water
molecul
interact
residu
specif
pocket
displac
upon
bind
substrateanalogu
inhibitor
probabl
exit
site
via
network
hydrogen
bond
water
molecul
form
back
end
specif
pocket
similar
scene
might
happen
hav
complex
keton
inhibitor
ia
ib
appar
bind
inhibitor
ii
hav
suffici
optim
expel
solvent
molecul
interact
site
consequ
inhibitor
ii
bind
deepli
pocket
mm
residu
inhibitor
ia
ib
provid
strong
evid
imidazol
ring
neutral
complex
otherwis
direct
hydrogen
bond
ionpair
interact
would
favor
opposit
scenario
sidechain
uncharg
neg
charg
carboxyl
sidechain
natur
favor
solventexpos
locat
addit
nonoptim
bind
residu
inhibitor
ii
site
also
contribut
shallow
penetr
pocket
compar
equival
atom
inhibitor
ia
ib
c
c
atom
inhibitor
ii
push
outward
solvent
respect
avoid
clash
benzen
figur
fit
initi
model
inhibitor
experiment
electron
densiti
near
catalyt
cystein
keto
carbonyl
carbon
cc
residu
adjac
carbon
c
inhibitor
place
within
atom
thu
episulfid
cation
fit
electron
densiti
far
better
singl
c
bond
either
cc
c
atom
although
relat
thiiranium
cation
bear
carbon
substitu
wellrecogn
intermedi
chemic
synthes
includ
especi
stabl
structur
character
exampl
best
knowledg
one
report
thiiranium
episulfid
cation
oxyanion
substitu
detect
intermedi
ga
phase
studi
final
model
hav
inhibitor
ia
distanc
atom
c
cc
respect
figur
imidazol
ring
coplanar
c
n
atom
distanc
c
respect
distanc
c
cc
correspond
cc
singl
bond
indic
physic
strain
well
distribut
around
entir
threememb
ring
cs
cc
angl
feasibl
due
fact
sulfur
larger
atom
radiu
either
oxygen
carbon
latter
element
would
abl
form
threememb
ring
structur
similar
stabil
perhap
epoxi
ether
intermedi
propos
develop
inactiv
serin
proteinas
chloromethyl
keton
inhibitor
observ
previou
crystal
structur
episulfid
ring
structur
inhibitor
ia
inhibitor
ib
complex
essenti
ident
tabl
figur
structur
refin
ii
complex
structur
use
coordin
episulfid
ring
ia
complex
reveal
addit
posit
electron
densiti
peak
near
atom
figur
c
fit
indic
repres
altern
mode
bond
inhibitor
character
singl
coval
linkag
c
inhibitor
ii
interestingli
mode
bond
correspond
observ
crystal
structur
inactiv
papain
coval
attach
chloromethyl
keton
compound
furthermor
rel
orient
methylketon
moieti
inhibitor
catalyt
cystein
histidin
residu
also
share
two
cystein
proteinas
differ
fold
nevertheless
two
enzym
made
differ
structur
adjust
arriv
conform
case
papain
imidazol
ring
inplan
atom
apoenzym
rotat
c
c
bond
becom
coplanar
atom
equival
n
atom
scissil
peptid
bond
ii
complex
structur
contain
episulfid
ring
atom
coplanar
c
atom
inhibitor
imidazol
ring
altern
conform
lack
ring
atom
posit
unchang
wherea
c
bond
rotat
toward
solvent
caus
atom
roll
common
plane
contain
imidazol
ring
c
new
posit
atom
cc
atom
inhibitor
ii
compar
averag
distanc
c
eight
methionin
residu
hav
molecul
comparison
three
structur
hav
bound
tetrapeptidyl
keton
inhibitor
ivf
complex
structur
pdb
code
suggest
episulfid
ring
structur
may
intermedi
state
ivf
inactiv
pathway
latter
structur
imidazol
ring
rotat
c
c
bond
roughli
becom
inplan
carbon
posit
ketomethylen
function
ivf
inhibitor
atom
judg
two
altern
conform
ii
complex
seem
possibl
intern
displac
reaction
would
resolv
episulfid
ring
eventu
form
alkyl
activ
site
howev
unclear
episulfid
cation
produc
first
place
least
three
potenti
rout
lead
format
episulfid
ring
figur
scheme
atom
attack
c
directli
nucleophil
substitut
reaction
replac
fluorid
would
follow
attack
lone
electron
pair
atom
carbonyl
carbon
form
oxyanion
episulfid
cation
scheme
ii
iii
atom
first
attack
carbonyl
carbon
form
tetrahedr
intermedi
oxyanion
scheme
ii
lone
electron
pair
displac
fluorid
scheme
iii
oxyanion
displac
fluorid
form
transient
epoxi
ether
rearrang
stabl
episulfid
ring
xray
crystallographi
show
snapshot
structur
interest
unless
one
propos
intermedi
speci
uniformli
form
stabli
preserv
crystal
experiment
tool
need
differenti
among
mechanist
pathway
although
none
reactiv
group
inhibitor
repres
true
peptid
bond
substrat
proteinas
chang
rel
orient
atom
imidazol
ring
substitut
methyl
carbonyl
group
inhibitor
nevertheless
agre
hypothes
role
catalyt
residu
hydrolyz
natur
peptidyl
substrat
assist
act
gener
base
catalyst
receiv
proton
therebi
produc
rel
strong
nucleophil
thiolat
ion
thiolat
subsequ
attack
carbonylcarbon
atom
scissil
bond
form
tetrahedr
intermedi
next
step
donat
proton
nitrogen
atom
residu
make
better
leav
group
follow
cleavag
peptid
bond
format
thiolacyl
enzym
fulfil
variou
role
mechan
must
adjust
orient
toward
accordingli
interestingli
two
predict
conform
pair
correspond
well
observ
two
ii
complex
structur
report
structur
enzym
inactiv
methyl
keton
inhibitor
sar
chloromethyl
keton
cmk
complex
pdb
code
structur
inhibitor
form
singl
bond
nucleophil
correspond
altern
mode
bond
observ
hav
ii
complex
complex
orient
regard
intermedi
two
bond
mode
observ
hav
ii
complex
similar
episulfid
ring
bind
mode
similar
intermedi
orient
also
observ
crystal
structur
complex
substrat
analogu
inhibitor
tabl
recent
crystal
structur
sar
proteinas
modifi
peptidylbas
epoxid
inhibitor
obtain
two
differ
crystal
form
pdb
code
remark
ringopen
reaction
inhibitor
enzym
coval
link
catalyt
sulfur
atom
atom
inhibitor
similar
posit
c
atom
halomethyl
keton
inhibitor
compar
apoenzym
structur
pdb
code
drastic
rotat
chang
angl
c
bond
catalyt
cystein
residu
reproduc
observ
two
differ
crystal
form
pdb
code
indic
proteinas
suggest
papain
may
undergo
local
signific
conform
chang
activ
site
hydrolysi
substrat
progress
inhibitor
aim
structur
trap
viral
enzym
one
intermedi
step
may
prove
extrem
effect
neutral
essenti
viral
compon
product
assay
hav
proteinas
synthesi
test
inhibitor
ib
experiment
procedur
enzym
product
assay
well
synthes
inhibitor
ia
ib
ii
figur
publish
follow
present
studi
enzym
inhibit
hmqc
nmr
experi
also
done
accord
procedur
describ
report
crystal
hav
proteinas
variant
grown
harvest
describ
make
inhibitor
tripl
complex
pregrown
crystal
soak
solut
contain
mm
substitut
methylketon
inhibitor
least
h
cryoprotect
flashcool
data
collect
prepar
sampl
mass
spectrometr
analysi
hav
crystal
soak
collect
rins
larg
excess
mother
liquor
remov
residu
peripher
presenc
inhibitor
xray
diffract
data
collect
beamlin
advanc
light
sourc
al
berkeley
lawrenc
nation
laboratori
program
denzo
scalepack
suit
use
process
scale
dataset
tabl
structur
solv
molecular
replac
use
program
molrep
program
suit
publish
model
hav
complex
pdb
code
search
probe
program
xfit
use
visual
finetun
model
build
adjust
program
use
refin
structur
crystallograph
refin
statist
list
tabl
qualiti
structur
assess
use
program
procheck
intra
intermolecular
contact
variou
crystal
structur
analyz
use
suit
program
contact
figur
prepar
use
program
pymol
http
wwwpymolorg
coordin
associ
structur
factor
deposit
rcsb
protein
data
bank
pdb
code
hav
complex
inhibitor
ia
ib
ii
complex
respect
